510 related articles for article (PubMed ID: 21900099)
1. Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.
Bladé J; Fernández de Larrea C; Rosiñol L; Cibeira MT; Jiménez R; Powles R
J Clin Oncol; 2011 Oct; 29(28):3805-12. PubMed ID: 21900099
[TBL] [Abstract][Full Text] [Related]
2. Impact of extramedullary plasmacytomas on outcomes according to treatment approach in newly diagnosed symptomatic multiple myeloma.
Lee SE; Kim JH; Jeon YW; Yoon JH; Shin SH; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Lee JW; Min WS; Park CW; Min CK
Ann Hematol; 2015 Mar; 94(3):445-52. PubMed ID: 25257340
[TBL] [Abstract][Full Text] [Related]
3. Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma.
Shin HJ; Kim K; Lee JW; Song MK; Lee JJ; Lee HS; Lee WS; Kim SJ; Chung JS
Eur J Haematol; 2014 Nov; 93(5):414-21. PubMed ID: 24813053
[TBL] [Abstract][Full Text] [Related]
4. Extramedullary disease in plasma cell myeloma: the iceberg phenomenon.
Wirk B; Wingard JR; Moreb JS
Bone Marrow Transplant; 2013 Jan; 48(1):10-8. PubMed ID: 22410751
[TBL] [Abstract][Full Text] [Related]
5. Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.
Alegre A; Granda A; Martínez-Chamorro C; Díaz-Mediavilla J; Martínez R; García-Laraña J; Lahuerta JJ; Sureda A; Bladé J; de la Rubia J; Fernández-Rañada JM; San Miguel J; ; ;
Haematologica; 2002 Jun; 87(6):609-14. PubMed ID: 12031917
[TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma with extramedullary disease.
Oriol A
Adv Ther; 2011 Nov; 28 Suppl 7():1-6. PubMed ID: 22105527
[TBL] [Abstract][Full Text] [Related]
7. Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.
Terpos E; Rezvani K; Basu S; Milne AE; Rose PE; Scott GL; Rahemtulla A; Samson D; Apperley JF
Eur J Haematol; 2005 Nov; 75(5):376-83. PubMed ID: 16191086
[TBL] [Abstract][Full Text] [Related]
8. Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
Rosiñol L; Beksac M; Zamagni E; Van de Donk NWCJ; Anderson KC; Badros A; Caers J; Cavo M; Dimopoulos MA; Dispenzieri A; Einsele H; Engelhardt M; Fernández de Larrea C; Gahrton G; Gay F; Hájek R; Hungria V; Jurczyszyn A; Kröger N; Kyle RA; Leal da Costa F; Leleu X; Lentzsch S; Mateos MV; Merlini G; Mohty M; Moreau P; Rasche L; Reece D; Sezer O; Sonneveld P; Usmani SZ; Vanderkerken K; Vesole DH; Waage A; Zweegman S; Richardson PG; Bladé J
Br J Haematol; 2021 Aug; 194(3):496-507. PubMed ID: 33724461
[TBL] [Abstract][Full Text] [Related]
9. Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome.
Zeiser R; Deschler B; Bertz H; Finke J; Engelhardt M
Bone Marrow Transplant; 2004 Dec; 34(12):1057-65. PubMed ID: 15516937
[TBL] [Abstract][Full Text] [Related]
10. Extramedullary multiple myeloma escapes the effect of thalidomide.
Rosiñol L; Cibeira MT; Bladé J; Esteve J; Aymerich M; Rozman M; Segarra M; Cid MC; Filella X; Montserrat E
Haematologica; 2004 Jul; 89(7):832-6. PubMed ID: 15257935
[TBL] [Abstract][Full Text] [Related]
11. Extensive extramedullary disease in myeloma. An uncommon variant with features of poor prognosis and dedifferentiation.
Sanal SM; Yaylaci M; Mangold KA; Pantazis CG
Cancer; 1996 Apr; 77(7):1298-302. PubMed ID: 8608506
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetics of extramedullary manifestations in multiple myeloma.
Billecke L; Murga Penas EM; May AM; Engelhardt M; Nagler A; Leiba M; Schiby G; Kröger N; Zustin J; Marx A; Matschke J; Tiemann M; Goekkurt E; Heidtmann HH; Vettorazzi E; Dierlamm J; Bokemeyer C; Schilling G
Br J Haematol; 2013 Apr; 161(1):87-94. PubMed ID: 23368088
[TBL] [Abstract][Full Text] [Related]
13. Three cases of bortezomib-resistant multiple myeloma with extramedullary masses.
Moriuchi M; Ohmachi K; Kojima M; Tsuboi K; Ogawa Y; Nakamura N; Ando K
Tokai J Exp Clin Med; 2010 Apr; 35(1):17-20. PubMed ID: 21319020
[TBL] [Abstract][Full Text] [Related]
14. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
[TBL] [Abstract][Full Text] [Related]
15. Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution.
Jiménez-Segura R; Rosiñol L; Cibeira MT; Fernández de Larrea C; Tovar N; Rodríguez-Lobato LG; Bladé E; Moreno DF; Oliver-Caldés A; Bladé J
Blood Cancer J; 2022 Sep; 12(9):135. PubMed ID: 36114167
[TBL] [Abstract][Full Text] [Related]
16. Association between intracranial plasmacytoma and multiple myeloma: clinicopathological outcome study.
Schwartz TH; Rhiew R; Isaacson SR; Orazi A; Bruce JN
Neurosurgery; 2001 Nov; 49(5):1039-44; discussion 1044-5. PubMed ID: 11846895
[TBL] [Abstract][Full Text] [Related]
17. Plasma cell neoplasms. Review of disease progression and report of a new variant.
Nolan KD; Mone MC; Nelson EW
Surg Oncol; 2005 Aug; 14(2):85-90. PubMed ID: 15993050
[TBL] [Abstract][Full Text] [Related]
18. Graft-versus-myeloma after donor leukocyte infusion: maintenance of marrow remission but extramedullary relapse with plasmacytomas.
Zomas A; Stefanoudaki K; Fisfis M; Papadaki T; Mehta J
Bone Marrow Transplant; 1998 Jun; 21(11):1163-5. PubMed ID: 9645583
[TBL] [Abstract][Full Text] [Related]
19. P53 deletion may drive the clinical evolution and treatment response in multiple myeloma.
López-Anglada L; Gutiérrez NC; García JL; Mateos MV; Flores T; San Miguel JF
Eur J Haematol; 2010 Apr; 84(4):359-61. PubMed ID: 20002730
[TBL] [Abstract][Full Text] [Related]
20. Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival.
Palumbo A; Attal M; Roussel M
Clin Cancer Res; 2011 Mar; 17(6):1253-63. PubMed ID: 21411441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
